z-logo
open-access-imgOpen Access
3 QUESTIONS ON... Important Differences Between Two New Prostate Cancer Drugs
Author(s) -
Sarah DiGiulio
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000722656.82361.fb
Subject(s) - olaparib , prostate cancer , parp inhibitor , medicine , oncology , cancer , dna damage repair , homologous recombination , poly adp ribose polymerase , family medicine , dna repair , cancer research , gene , polymerase , genetics , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom